1-4 of 4
Yaohua He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT128: Effect of futibatinib on QT/QTc interval: a randomized, controlled, double-blind study

Ikuo Yamamiya, John Laabs, Daryl Sonnichsen, Mark Mina, Yaohua He, Karim Benhadji
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT128.
DOI: https://doi.org/10.1158/1538-7445.AM2021-CT128
Published: 01 July 2021
View article
Journal Articles

Abstract CT010: Primary results of phase 2 FOENIX-CCA2: The irreversible FGFR1-4 inhibitor futibatinib in intrahepatic cholangiocarcinoma (iCCA) with FGFR2 fusions/rearrangements

Lipika Goyal, Funda Meric-Bernstam, Antoine Hollebecque, Chigusa Morizane, Juan W. Valle, Thomas B. Karasic, Thomas A. Abrams, Robin Kate Kelley, Philippe Cassier, Junji Furuse, Heinz-Josef Klümpen, Heung-Moon Chang, Li-Tzong Chen, Yoshito Komatsu, Kunihiro Masuda, Daniel Ahn, Yaohua He, Nital Soni, Karim A. Benhadji, John A. Bridgewater
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT010.
DOI: https://doi.org/10.1158/1538-7445.AM2021-CT010
Published: 01 July 2021
View article
Journal Articles

Abstract CT125: Evaluation of potential drug-drug interactions (DDIs) between futibatinib and CYP3A inhibitors/inducers, CYP3A substrates, or proton pump inhibitors (PPIs)

Ikuo Yamamiya, John Laabs, Allen Hunt, Toru Takenaka, Daryl Sonnichsen, Mark Mina, Yaohua He, Karim Benhadji
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): CT125.
DOI: https://doi.org/10.1158/1538-7445.AM2021-CT125
Published: 01 July 2021
View article
Journal Articles

Abstract OT2-07-01: A phase 2 study of futibatinib (TAS-120) in metastatic breast cancers harboring fibroblast growth factor receptor (FGFR) amplifications (FOENIX-MBC2)

Nick C. Turner, Ian E. Krop, Aditya Bardia, Senthil Damodaran, Miguel Martin, Karim A. Benhadji, Yaohua He, Mieke Ptaszynski, Carlos L. Arteaga
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT2-07-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-OT2-07-01
Published: 15 February 2020
View article